IFN-α在SLE病理机制中的启动和维持作用
摘要
SLE的发病过程中存在T细胞凋亡、T细胞数量减少以及自身反应性T、B细胞活化和树突状细胞、调节性T细胞的异常。近年来的研究发现,IFN-α与上述免疫学异常密切相关,在SLE的发病机制中起重要作用。本文就近年来SLE体内IFN-α的产生和免疫病理作用的研究进展作一综述。
出处
《国外医学（免疫学分册）》
2005年第6期361-365,共5页
Foreign Medical Sciences(Section of Immunology Foreign Medical Sciences)
参考文献20
-
1Bave U,Mattias M,Maija-Leena E,et al.FcγRⅡa is expressed on natural IFN-α-producing cells (plasmacytoid dendritic cells) and is required for the IFN-α production induced by apoptotic cells combined with lupus IgG[J].J Immunol,2003,171:3296-3302.
-
2Wilson LE,Widman D,Dikman SH,et al.Autoimmune disease complicating antiviral therapy for hepatitis C virus infection[J].Semin Arthritis Rheum,2002,32:163-173.
-
3Ronnblom L,Gunnar VA.A pivotal role for the natural interferon-α-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus[J].J Exp Med,2001,12:F59-F63.
-
4Yang GX,Lian ZX,Kentaro K,et al.CD4- plasmacytoid dendritic cells (PDCs) migrate in lymph nodes by CpG inoculation and represent a potent functional subset of PDCs[J].J Immunol,2005,174:3197-3203.
-
5Ronnelid J,Tejde A,Mathsson L,et al.Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcγRⅡ dependent mechanism:implications for a possible vicious cycle maintaining B cell hyperactivity in SLE[J].Ann Rheum Dis,2003,62:37-42.
-
6Bave U,Gunnar VA,Ronnblom L.The Combination of Apoptotic U937 Cells and Lupus IgG Is a Potent IFN-a Inducer[J].J Immunol,2000,165:3519-3526.
-
7Miyata M,Ito O,Kobayashi H,et al.CpG-DNA derived from sera in systemic lupus erythematosus enhances ICAM-1 expression on endothelial cells[J].Ann Rheum Dis,2001,60:685-689.
-
8Viglianti GA,Lau CM,Hanley TM,et al.Activation of autoreactive B cells by CpG dsDNA[J].Immunity,2003,19:837-847.
-
9Qun L,Chen D,Max DC.Impairment of T and B cell development by treatment with a type-Ⅰ interferon[J].J Exp Med,1998,187(1):79-87.
-
10King C,Ilic A,Koelsch K,et al.Homeostatic expansion of T cells during immune insufficiency generates autoimmunity[J].Cell,2004,117(2):265-277.
二级参考文献34
-
1[11]Gross JA et al. Nature, 2000, 404(6781): 995-999
-
2[12]Stohl WArthritis Res, 2003, 5(3): 136-138
-
3[13]Schiemann B et al. Science, 2001, 293(5537): 2111-2114
-
4[14]Gescuk BD et al. Curr Opin Rheumatol, 2002, 14(5): 515-521
-
5[1]Do RK et al. Cytokine Growth Factor Rev, 2002, 13(1): 19-25
-
6[2]Nardelli B et al. Blood, 2001, 97(1): 198-204
-
7[3]Shu HB et al. J Leukoc Biol, 1999, 65(5): 680-683
-
8[4]Thompson JS et al. Science, 2001, 293(5537): 2108-2111
-
9[5]Mackay F et al. J Exp Med, 1999, 190(11): 1697-1710
-
10[6]Khare SD et al. Proc Natl Acad Sci USA, 2000, 97(7): 3370-3375
-
1任永刚,刘积伦,武胜.替米沙坦联合胺碘酮治疗冠心病并发阵发性房颤[J].中西医结合心脑血管病杂志,2011,9(9):1115-1116. 被引量：5
-
2罗健康,刘中祥,丁俐,黄时雨.氯沙坦对阵发性心房颤动维持窦性心律的研究[J].中国临床医生杂志,2009,37(4):34-35. 被引量：3
-
3李亚玲,程亚玲,易全会.替米沙坦联合胺碘酮治疗高血压合并阵发性房颤疗效观察[J].求医问药（下半月刊）,2011,9(6):167-168. 被引量：5
-
4韩凤波,刘军,周志兰.阿托伐他汀联合胺碘酮治疗阵发性心房颤动效果观察[J].中国综合临床,2012,28(7):707-709. 被引量：7
-
5袁红,冯天元,徐建,孙金栋,史明娟,於华敏.伊贝沙坦对心房颤动复发率的影响[J].医药导报,2005,24(3):187-188.
-
6陈洁,吴常达,包蓓艳.胺碘酮联合阿托伐他汀治疗慢性肾脏病3期伴阵发性心房颤动的临床研究[J].现代实用医学,2010,22(11):1279-1280. 被引量：4
-
7刘积伦,王玉君,高爱红,田燕妮,李军朋.贝那普利联合胺碘酮治疗高血压病伴阵发性心房颤动临床研究[J].河北医科大学学报,2008,29(4):561-563. 被引量：5
-
8史海中.缬沙坦对阵发性心房纤颤患者窦性心律的维持作用[J].现代中西医结合杂志,2011,20(34):4368-4369. 被引量：1
-
9张小伟.缬沙坦对伴高血压的阵发性房颤患者窦性心律的维持作用[J].浙江医学,2011,33(3):422-423.
-
10丁平,李莉,张浩,陈良金,邓学军,袁义强.厄贝沙坦与胺碘酮联合对风湿性心脏病持续性心房颤动转复患者的窦性心律维持作用[J].中华心血管病杂志,2009,37(6):505-508. 被引量：22
